Selected Publications

Cohen DL, Wachtel H, Vaidya A, Hundemer GL, Tezuka Y, Davio A, Turcu AF, Cohen JB: Primary Aldosteronism in Chronic Kidney Disease: Blood Pressure Control and Kidney and Cardiovascular Outcomes After Surgical vs. Medical Management. Hypertension. 80(10): 2187-2195, Oct 2023.

Cohen JB, Bress AP: Entering a New Era of Antihypertensive Therapy. Am J Kidney Dis. Online ahead of print, Nov 6 2023 Notes: DOI: 10.1053/j.ajkd.2023.09.009.

Cohen JB, Brown NJ, Brown S-A, Dent S, van Dorst DCH, Herrmann SM, Lang NN, Oudit GY, Touyz RM: Cancer Therapy-Related Hypertension: A Scientific Statement from the American Heart Association. Hypertension. 80(3): e46-e57, Mar 2023.

Cohen JB, Mitchell GF, Gill D, Burgess S, Rahman M, Hanff T, Ramachandran VS, Mutalik K, Townsend RR, Chirinos JA : Arterial Stiffness and Diabetes Mellitus Risk in the Framingham Heart Study and United Kingdom Biobank. Circ Res. 131(6): 545-554, Sep 2022.

Shulman R, Cohen JB: Resistant Hypertension in Chronic Kidney Disease: A Burden unto Itself. Clin J Am Soc Nephrol. 17(10): 1436-1438, Oct 2022.

Cohen JB, Marcum ZA, Zhang C, Derington CG, Greene TH, Ghazi L, Herrick JS, King JB, Cheung AK, Bryan N, Supiano MA, Sonnen JA, Weintraub WS, Scharfstein D, Williamson J, Pajewski NM, Bress AP: Risk of Mild Cognitive Impairment or Probable Dementia in New Users of Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors: A Secondary Analysis of Data From the Systolic Blood Pressure Intervention Trial (SPRINT). JAMA Netw Open. 5(7): e2220680, Jul 2022.

Cohen JB, Brady TM: Validation of Blood Pressure Device Accuracy: When the Bottom Line is Not Enough. Circulation. 145(2): 94-96, Jan 2022.

Cohen JB, Cohen DL, Herman DS, Leppert JT, Byrd JB, Bhalla V: Testing for Primary Aldosteronism and Mineralocorticoid Receptor Antagonist Use Among US Veterans: A Retrospective Cohort Study. Ann Intern Med. 174(3): 289-297, Mar 2021.

Cohen JB, Hanff TC, William P, Sweitzer N, Rosado-Santander NR, Medina C, Rodriguez-Mori JE, Renna N, Chang TI, Corrales-Medina V, Andrade-Villanueva JF, Barbagelata A, Cristodulo-Cortez R, Diaz-Cucho OA, Spaak J, Alfonso CE, Valdivia-Vega R, Villavicencio-Carranza M, Ayala-García RJ, Castro-Callirgos CA, González-Hernández LA, Bernales-Salas EF, Coacalla-Guerra JC, Salinas-Herrera CD, Nicolosi L, Basconcel M, Byrd JB, Sharkoski T, Bendezu-Huasasquiche LE, Chittams J, Edmonston DL, Vasquez CR, Chirinos JA: Continuation versus Discontinuation of Renin–Angiotensin System Inhibitors in Patients Admitted to Hospital with COVID-19: A Prospective, Randomised, Open-Label, Blinded Endpoint Trial. Lancet Resp Med. 9(3): 275-284, Mar 2021.

Rethy LB, Feinstein MJ, Achenbach CJ, Townsend RR, Bress AP, Shah SJ, Cohen JB: Antihypertensive Class and Cardiovascular Outcomes in Patients with HIV and Hypertension. Hypertension. 77(3): 2023-2033, Jun 2021.